Plain-English translation of NCT07780500 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hypertension research guide →This research study is looking at high blood pressure in a real-world setting—specifically, how doctors are treating it today and whether a hormone imbalance called primary aldosteronism plays a role in some patients' high blood pressure. About 500 people with high blood pressure will be invited to participate by providing blood and urine samples at a few visits over six months.
New medical guidelines from 2025 suggest that doctors should screen more patients for a hormone imbalance that can cause high blood pressure to be harder to control. This study will help doctors understand how common this imbalance is, how well current treatments are working, and how to better personalize care for each patient.
You likely qualify if…
You likely don't qualify if…
If you join, you will visit the clinic at the start (Month 0), and again at Month 2 and Month 6. At each visit, your blood pressure will be checked, your body composition will be measured, and blood and urine samples will be collected. The visits are straightforward outpatient appointments designed to fit into your regular care at Kaiser Permanente.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States
Sponsor
Kaiser Permanente
Collaborators
AstraZeneca
Enrollment target
~500 participants
Started
August 2026
Primary completion
March 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ankeet S Bhatt, MD, MBA, ScM
Kaiser Permanente
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.